Related Experiment Video
Updated: Feb 20, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Idiopathic catastrophic thrombosis with happy ending
Julia Heid1, Andreas Greinacher2, Hugo A Katus1
1Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany.
This case report details a patient with recurrent stent thrombosis and a complex clotting disorder. Despite treatment for heparin-induced thrombocytopenia (HIT), a catastrophic thrombotic syndrome persisted, suggesting other factors like massive thrombin generation.
Area of Science:
- Cardiology
- Hematology
- Thrombosis Research
Background:
- A 59-year-old male presented with ST-segment elevation myocardial infarction.
- The patient had a high-risk profile for heparin-induced thrombocytopenia (HIT).
Observation:
- The patient experienced three life-threatening in-stent thromboses despite initial resuscitation and treatment.
- Argatroban therapy, used for suspected HIT after the second reinfarction, did not prevent a third reinfarction.
- Further thrombotic events included deep vein thrombosis and an intracardiac thrombus, necessitating high-risk cardiac bypass surgery.
Findings:
- Despite positive HIT screening and a single positive heparin-induced platelet aggregation test, HIT was questioned as the sole cause.
- Consistently high D-dimer levels and the requirement for substantial direct thrombin inhibitor suggest massive thrombin generation as a potential driver.
- This points to a complex thrombotic syndrome beyond typical HIT.
Implications:
- Highlights the potential for severe cardiac complications in patients with complex clotting disorders.
- Emphasizes the need for comprehensive diagnostic and therapeutic strategies in unusual thrombotic scenarios.
- Suggests considering alternative or additional prothrombotic mechanisms when standard HIT treatment fails.
More Related Videos
09:14Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
09:35A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...